Official UK procurement notice
Biofoundry - Continuous RNA-LNP manufacture equipment
Authority: CENTRE FOR PROCESS INNOVATION LIMITED (Public body)
What is being bought
Published requirement descriptionCPI require equipment to manufacture DNA to support the Biofoundry programme. This equipment is specifically designated in the business case and forms part of the programme from OLS via Innovate UK.
This equipment forms the first stage of the Biofoundry process, producing the synthetic DNA templates that are essential to supply in-vitro transcription (IVT) and the subsequent RNA-LNP manufacturing workflow
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record- Procedure method
- Direct award
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 20 Oct 2025, 10:36 BST
- Last source update
- 27 Oct 2025, 14:09 GMT
- FTS notice number
2025/S 000-068570- Latest notice
- Contract award notice (UK6)
- Delivery area
- Not published
- Official registry OCID
ocds-h6vhtk-05cf82Find a Tender
- Why no open competition
- Prototypes Development; Single Suppliers Intellectual Property Exclusive Rights
- Published justification
The equipment is a prototype developed specifically to enable the Biofoundy the capability of being a 'DNA printer'. Forming a core element of the Biofoundry, it will allow bespoke DNA to be printed to support the manufacture of RNA-LNP. It will allow multiple, complex DNA candidates to be manufactured quickly, in house for a reasonable price. Facilitating the Biofoundry model.
The UK Biofoundry forms part of the broader worldwide Biofoundy network. Initiated by the charity, Wellcome Leap inc, the vision is to enable early-stage academics and SME's access to cost effective RNA-LNP to enable more shots on goal with this life changing technology while enhancing the worlds pandemic readiness. The Biofoundry network, via Wellcome Leap, has directly funded development of the UK Biofoundry equipment.
How it was run
Official notice- Submission deadline
- —
Timeline
27 Oct 2025 → 5 Nov 2025 · 2 dates- Notice published365 days ago27 Oct 2025, 14:09 GMT
- Standstill ends356 days ago5 Nov 2025, 23:59 GMT
Notice history
5 events · 4 releases on Find a Tender · since 20 Oct 2025- Transparency notice published20 Oct 2025, 10:36 BSTUK5
- Transparency notice published20 Oct 2025, 10:41 BSTUK5
- Transparency notice published22 Oct 2025, 13:17 BSTUK5
- Contract award notice published27 Oct 2025, 14:09 GMTUK6
- Contract signature expected11 Nov 2025, 23:59 GMTscheduled
Routine re-releases (4)
- 2025-10: 1 release · 20 Oct 2025
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Centillion Technology, RiboPro B.Vjoint award12 Nov 2025 – 9 May 2027 · up to 15 Sept 2028Extensions: A further machine will be procured from one of the supplier. It is also expected that variations to contract maybe required for extra support and upgrades | £8,863,985 inc. VAT | 27 Oct 2025standstill to 5 Nov 2025 | Standstill |
Contracting authority & participating public bodies
Bidders & participating suppliers
2 commercial parties on the notice- Centillion TechnologyAwarded supplier
- RiboPro B.VAwarded supplier
Official documents & specifications (4)
Official links; attachments are not copiedNotices published for this procedure
- Contract award notice Contract award notice on Find a Tender
- Transparency notice Transparency notice on Find a Tender
- Transparency notice Transparency notice on Find a Tender
- Transparency notice Transparency notice on Find a Tender